Pregled bibliografske jedinice broj: 948325
Serum chitotriosidase : a circulating biomarker in polycythemia vera
Serum chitotriosidase : a circulating biomarker in polycythemia vera // Hematology (Luxembourg), 23 (2018), 10; 793-802 doi:10.1080/10245332.2018.1498157 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 948325 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Serum chitotriosidase : a circulating biomarker in
polycythemia vera
Autori
Krečak, Ivan ; Gverić-Krečak, Velka ; Rončević, Pavle ; Bašić-Kinda, Sandra ; Gulin, Josipa ; Lapić, Ivana ; Fumić, Ksenija ; Ilić, Ivana ; Horvat, Ivana ; Zadro, Renata ; Holik, Hrvoje ; Coha, Božena ; Peran, Nena ; Aurer, Igor ; Duraković, Nadira
Izvornik
Hematology (Luxembourg) (1024-5332) 23
(2018), 10;
793-802
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Chitinase ; biomarker ; chitotriosidase ; cytokines ; essential thrombocythemia ; myelofibrosis ; myeloproliferative neoplasm ; polycythemia vera
Sažetak
Serum chitotriosidase activity (CHIT1) is a biomarker of macrophage activation with an important role in inflammation-induced tissue remodeling and fibrosis. Macrophages have been described to play a crucial role in regulating pathological erythropoiesis in polycythemia vera (PV). The aim of this study was to evaluate CHIT1 in patients diagnosed with Philadelphia-negative myeloproliferative neoplasms (MPNs). Using fluorometric assay, we measured CHIT1 in 28 PV, 27 essential thrombocythemia (ET), 17 primary myelofibrosis (PMF), 19 patients with secondary myelofibrosis and in 25 healthy controls. CHIT1 was significantly higher in PV (p < .001) and post- PV myelofibrosis (MF) transformation (post- PV MF) (p = .020), but not in ET (p = .080), post- ET MF transformation (p = .086), and PMF patients (p = .287), when compared to healthy controls. CHIT1 in PV was positively correlated with hemoglobin (p = .026), hematocrit (p = .012), absolute basophil count (p = .030) and the presence of reticulin fibrosis in the bone marrow (p = .023). A positive correlation between CHIT1 and these distinct laboratory PV features might imply macrophages closely related to clonal erythropoiesis as cells of CHIT1 origin. In addition, a positive association between CHIT1 and reticulin fibrosis might indicate its potential role in PV progression. CHIT1 might be considered as a circulating biomarker in PV. Additional studies are needed to clarify the role of CHIT1 in promoting disease progression and bone marrow fibrosis in PV.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb,
Medicinski fakultet, Zagreb,
Opća bolnica Šibenik,
Opća bolnica "Dr. Josip Benčević",
Klinički bolnički centar Zagreb
Profili:
Božena Coha
(autor)
Renata Zadro
(autor)
Ivana Ilić
(autor)
Ivana Lapić
(autor)
Velka Gverić-Krečak
(autor)
Ivana Horvat
(autor)
Igor Aurer
(autor)
Ksenija Fumić
(autor)
Nena Peran
(autor)
Nadira Duraković
(autor)
Hrvoje Holik
(autor)
IVAN KREČAK
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
Uključenost u ostale bibliografske baze podataka::
- EMBASE (Excerpta Medica)
- CML LEUKAEMIA AND LYMPHOMA